Profile
ABVX NVO VRTX REGN SGEN ARGX
Company Name Abivax SA American Depositary Shares Novo Nordisk A/S Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $527.91M $484.44B $119.94B $82.39B $43.15B $37.28B
Employees 0.06K 71.88K 5.40K 14.17K 3.26K 1.15K
CEO Mr. Marc M. P. de Garidel M.B.A. Mr. Lars Fruergaard Jorgensen Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Ratings
ABVX NVO VRTX REGN SGEN ARGX
Quant Rating Score 1 3 3 4 3 1
Quant Rating Strong Sell Neutral Neutral Buy Neutral Strong Sell
Trading
ABVX NVO VRTX REGN SGEN ARGX
Last Close $8.48 $108.67 $465.73 $762.34 $228.74 $617.49
High 52 $15.89 $146.91 $516.74 $1201.76 $228.74 $617.49
Low 52 $8.49 $101.74 $392.81 $738 $228.74 $356.01
Price vs. 52 Week High -46.63 % -26.03 % -9.87 % -36.56 % 0 % 0 %
Price vs. 52 Week Low -0.12 % 6.81 % 18.56 % 3.3 % 0 % 73.45 %
Total Return
ABVX NVO VRTX REGN SGEN ARGX
1 Month Return -17.43 % -2.92 % -1.14 % -9.63 % 0 % 3.68 %
3 Month Return -31.67 % -20.25 % -2.1 % -34.78 % 0 % 20.08 %
6 Month Return -37.09 % -19.87 % -0.95 % -22.96 % 0 % 63.39 %
9 Month Return -39.17 % -12.53 % 7.62 % -22.43 % 0 % 56.93 %
YTD Return -20.75 % 5.05 % 14.46 % -13.2 % 0 % 62.31 %
1 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABVX NVO VRTX REGN SGEN ARGX
Dividend Yield Percentage (TTM) - 1.26 % - - - -
Dividend Paid and Capex Coverage Ration (TTM) -438.26 % 1.25 % -2.62 % 4.88 % -2.27 % -2.22 %
Dividend Per Share (TTM) - 9.9 % - - - -
Payout Ratio (TTM) - 46.6 % - - - -
Growth
ABVX NVO VRTX REGN SGEN ARGX
Asset Growth 345.88 % 30.35 % 25.23 % 13.23 % -1.21 % 44.93 %
Gross Profit Growth -12.5 % 32.32 % 9.64 % 6.49 % 22.93 % 190.7 %
Revenue Growth 0.83 % 31.26 % 10.51 % 7.76 % 24.65 % 198.56 %
Revenue 3 Year 2336.82 % 90.03 % 60.36 % 55.67 % 91.56 % 2071.96 %
Revenue 5 Year 5965.58 % 123.63 % 219.55 % 110.3 % 215.48 % 3041.46 %
Revenue 10 Year 1228.76 % 65.69 % 610.45 % 549.62 % 494.04 % 9009.53 %
EBIT Growth -124.87 % 37.11 % 0 % -14.6 % 10.13 % 40.94 %
Net Income Growth -111.52 % 50.71 % 8.96 % -8.87 % 9.51 % 58.42 %
Net Income 3 Yeari Growth Per Share -30.71 % 106.26 % 34.59 % 13.48 % -763.59 % 64.01 %
Net Income 5 Yeari Growth Per Share -120.61 % 133.27 % 70.33 % 74.02 % -276.93 % -143.65 %
Net Income 10 Yeari Growth Per Share -439.7 % 98.1 % 809.6 % 871.12 % -624.16 % -857 %
Operating Income Growth -124.87 % 37.11 % 0 % -14.6 % 10.13 % 40.94 %
Operating Cash Flow Growth (CFG) -257.32 % 38.06 % -14.35 % -8.39 % 9.07 % 51.28 %
Operating 3 Year CFG -11.41 % 117.73 % 9.63 % 76.95 % -147.99 % 21.71 %
Operating 5 Year CFG -61.81 % 162.84 % 174.78 % 125.17 % -195.86 % -329.63 %
Operating 10 Year CFG - 150.28 % 6084.35 % 713.56 % -2622.09 % -1280.2 %
EPS Growth -9.58 % 51.88 % 8.33 % -8.54 % 10.81 % 60.46 %
EPS Diluted Growth -9.58 % 52.37 % 8.35 % -9.03 % 10.81 % 60.46 %
Book Value Per Share 1066.55 % 28.67 % 25.58 % 15.03 % -9.83 % 38.53 %
Share Holder 3 Year Equity Growth Per Share 263.79 % 74.77 % 104.06 % 137.56 % 33.72 % 93.75 %
Share Holder 5 Year Equity Growth Per Share 33.64 % 121.34 % 291.14 % 219.1 % 220.81 % 318.81 %
Share Holder 10 Year Equity Growth Per Share 24.05 % 49.24 % 1030.79 % 1286.9 % 691.19 % 3654.06 %
Dividend Per Share Growth - 26.56 % - - - -
Dividend 3 Year Growth Per Share - 63.98 % - - - -
Dividend 5 Year Growth Per Share - 79.57 % - - - -
Dividend 10 Year Growth Per Share - 94.94 % - - - -
Debt Growth 20.4 % 4.74 % 44.1 % 0.06 % -23.28 % 60.95 %
Free Cash Flow Growth -257.72 % 9.17 % -16.47 % -17.11 % 3.67 % 51.98 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2022 31 Dec 2023
Profitability
ABVX NVO VRTX REGN SGEN ARGX
Gross Profit Margin TTM 95.81 % 84.66 % 86.1 % 84.42 % 72.37 % 86.82 %
Return on Assets TTM -62.37 % 23.83 % -2.16 % 12.43 % -11.76 % -2.13 %
Return on Equity TTM -110.04 % 86.4 % -2.88 % 16.85 % -16.53 % -2.75 %
Return on Capital Employed TTM -83.2 % 62.74 % -1.72 % 11.85 % -16.87 % -8.98 %
Net Income Per EBT TTM 98.52 % 79.43 % -184.82 % 93.66 % 100.55 % 167.72 %
EBT Per Ebit TTM 105.83 % 100.52 % -82.68 % 124.1 % 94.01 % 15.76 %
EBIT Per Revenue TTM -1884.33 % 43.84 % -2.96 % 28.92 % -36.09 % -17.08 %
Cash Flow To Debt Ratio TTM -139.2 % 207.5 % - 214.08 % -185.98 % -
Receivables Turnover TTM - 3.89 6.06 2.27 1.98 3.45
Payables Turnover TTM 0.02 1.72 3.73 4.34 1.54 1.06
Inventory Turnover TTM - 1.09 1.37 0.71 0.65 0.91
Fixed Asset Turnover TTM 350.85 % 225.8 % 422.11 % 311.93 % 256.83 % 6116.64 %
Asset Turnover TTM 3.17 % 68.08 % 47.71 % 36.98 % 34.46 % 47.09 %
Operating Cash Flow Per Share TTM -2.46 26.54 -3.27 39.29 -1.12 -2.42
Free Cash Flow Per Share TTM -2.46 15.14 -4.51 31.25 -1.62 -3.52
Cash Per Share TTM 353.34 % 1681.33 % 2528.88 % 9062.44 % 657.5 % 5163.05 %
Operating Cash Flow Sales Ratio TTM -1713.06 % 43.69 % -7.94 % 30.67 % -16.85 % -6.44 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.23 % 57.03 % 138.12 % 79.52 % 144.14 % 145.12 %
Cash Flow Coverage Ratios TTM -139.2 % 207.5 % - 214.08 % -185.98 % -
Price To Free Cash Flows Ratio TTM -3.13 50.3 -103.06 24.39 -141.85 -176.49
Price To Operating Cash Flows Ratio TTM -3.12 29.51 -142.6 19.4 -203.89 -254.93
Price Cash Flow Ratio TTM -3.12 29.51 -142.6 19.4 -203.89 -254.93
Income Statement (TTM)
ABVX NVO VRTX REGN SGEN ARGX
Revenue $0B $232.26B $9.87B $13.12B $1.96B $1.23B
Gross Profit $0B $196.5B $8.61B $11.3B $1.55B $1.11B
Gross Profit Ratio 84.7% 84.6% 87.21% 86.16% 79.1% 90.39%
EBITDA $-0.13B $114.63B $4.61B $4.69B $-0.62B $-0.22B
Net Income $-0.15B $83.68B $3.62B $3.95B $-0.61B $-0.3B
EPS Diluted -3.43 18.62 13.89 34.77 -3.3 -5.16
Balance Sheet (MRQ)
ABVX NVO VRTX REGN SGEN ARGX
Long Term Debt $0.04B $20.53B $1.45B $2.7B $0.04B $0.02B
Total Liabilities $0.13B $207.93B $5.15B $7.11B $0.87B $0.44B
Total Equity $0.2B $106.56B $17.58B $25.97B $2.8B $4.1B
Total Investments $0.02B $17.5B $3.45B $13.51B $1.42B $1.18B
Total Debt $0.06B $27.01B $0.81B $2.7B $0.04B $0.02B
Total Assets $0.33B $314.49B $22.73B $33.08B $3.67B $4.54B
Cash Flow Statement (TTM)
ABVX NVO VRTX REGN SGEN ARGX
Net Income $-0.15B $83.68B $3.62B $3.95B $-0.61B $-0.43B
Inventory $0B $-7.42B $-0.32B $-0.27B $-0.23B $-0.08B
Dividends Paid $0B $-31.77B $0B $0B $0B $0B
Operating Cash Flow $-0.1B $108.91B $3.54B $4.59B $-0.45B $-0.42B
Capital Expenditure $-0B $-38.9B $-0.26B $-0.93B $-0.08B $-0.04B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.48
ABCL AbCellera Biologics Inc. 2.91
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 6.11
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.28
ABSI Absci Corporation 2.99
ABUS Arbutus Biopharma Corporation 3.41
ABVC ABVC BioPharma, Inc. 0.54
ACAD ACADIA Pharmaceuticals Inc. 16.3
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 1.1
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.07
ACHV Achieve Life Sciences, Inc. 4.56
ACIU AC Immune SA 3.21
ACLX Arcellx, Inc. 88.65
ACRV Acrivon Therapeutics, Inc. Common Stock 7.45
ACST Acasti Pharma Inc. 3.37
ACXP Acurx Pharmaceuticals, Inc. 0.912
ETFs With Exposure to ABVX
Ticker ETF Name Weight Percentage Price
DBEZ Xtrackers MSCI Eurozone Hedged Equity ETF 0.00368005 45.9299
BOUT Innovator IBD Breakout Opportunities ETF 2.56 41.61
SPEU SPDR Portfolio Europe ETF 0.002003 41.26
SXRJ.DE iShares VII PLC - iShares MSCI EMU Small Cap UCITS ETF EUR (Acc) 0.0665 266.55
CES1.L iShares VII PLC - iShares MSCI EMU Small Cap UCITS ETF EUR (Acc) 0.0865 22155
Unlock